Omeprazole and Anzemet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omeprazole (omeprazole) and Anzemet (dolasetron mesylate). Common drug interactions include anxiety among females and hypomagnesaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Omeprazole and Anzemet. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

On Jul, 26, 2026

28 people who take Omeprazole and Anzemet together, and have interactions are studied.

Omeprazole and Anzemet drug interactions.

What are the common drug interactions of Omeprazole and Anzemet, by gender? *:

female:

Anxiety
Arteriosclerosis (thickening and hardening of arteries)
Attention deficit/hyperactivity disorder
Axillary mass
Blood potassium decreased
Bone disorder
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bone marrow failure
Brachial plexopathy (pain, decreased movement, or decreased sensation in the arm and shoulder due to a nerve problem)
Breast cancer metastatic

male:

Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Thrombocytopenia (decrease of platelets in blood)
Hypokalaemia (low potassium)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Lymphadenopathy (disease or enlargement of lymph nodes)
Lymphatic obstruction (blockage in lymphatic duct)
Pain
Pleural effusion (water on the lungs)
Pyrexia (fever)
Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Omeprazole and Anzemet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Bradycardia (abnormally slow heart action)

30-39:

n/a

40-49:

Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bone marrow failure
Brachial plexopathy (pain, decreased movement, or decreased sensation in the arm and shoulder due to a nerve problem)
Breast cancer metastatic
Cervical spinal stenosis (narrowing of the spinal canal in the neck)
Chest pain
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
Colonic stenosis (abnormal narrowing of colon)
Compression fracture (fracture due to pressure caused by injury)

50-59:

n/a

60+:

Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Chest pain
Contusion (a type of hematoma of tissue in which capillaries)
Cough
Death
Decreased appetite
Dyspnoea (difficult or laboured respiration)
Dyspnoea exertional (breathlessness or shortness of breath)
Fatigue (feeling of tiredness)
Gait disturbance

What are the existing conditions these people have? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 17.86%
Multiple Myeloma (cancer of the plasma cells): 3 people, 10.71%
Metastases To Bone (cancer spreads to bone): 3 people, 10.71%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 10.71%
Immune System Disorder: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and Anzemet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously